Bahleda, R., Varga, A., Bergé, Y., Soria, J., Schnell, D., Tschoepe, I., . . . Delord, J. (2018). Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2. Br J Cancer.

Bahleda, Rastislav, Andrea Varga, Yann Bergé, Jean-Charles Soria, David Schnell, Inga Tschoepe, Martina Uttenreuther-Fischer, and Jean-Pierre Delord. "Phase I Open-label Study of Afatinib Plus Vinorelbine in Patients With Solid Tumours Overexpressing EGFR And/or HER2." Br J Cancer 2018.

Bahleda, Rastislav, et al. "Phase I Open-label Study of Afatinib Plus Vinorelbine in Patients With Solid Tumours Overexpressing EGFR And/or HER2." Br J Cancer 2018.